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Summary A hospital-based case-control study was undertaken to examine the role of human papillomavirus
(HPV) in the development of invasive cervical cancer in Brazil. The study included 199 histologically
confirmed incident cases and 225 age-frequency-matched controls selected from a wide range of diagnostic
categories. A polymerase chain reaction technique was used to detect HPV DNA in cervical specimens
collected with spatula and brush. HPV DNA was detected in 84% of the cases compared with 17% of
controls. Grouping HPV types 16, 18, 31 and 33, 66% of the cases were positive compared with only 6% of
the controls. In addition to HPV, number of sexual partners, early age at first intercourse, parity and duration
of oral contraceptive use were significantly associated with an increased risk of cervical cancer. A history of
previous Papanicolaou smears was significantly associated with a decreased risk. After adjustment, only
presence of HPV DNA, parity and history of previous smears remained as independent risk factors. The
adjusted odds ratios of cervical cancer associated with HPV 16, 18, 31, and 33 was 69.7 (95% confidence
interval 28.7-169.6) and with unidentified types was 12.0 (5.1-28.5). The very high risks found in this study
further implicate this virus in the aetiology of cervical cancer.
Epidemiological investigations have shown consistently that
measures of sexual behaviour, such as number of sexual
partners and early age at first intercourse, are major deter-
minants of cervical neoplasia (Franco, 1991), suggesting a
sexually transmitted agent as a likely cause. Impressive
experimental data have been accumulated to support an
aetiological role for human papillomavirus (HPV) in the
pathogenesis of anogenital cancer, especially cervical cancer
(Howley, 1991; zur Hausen, 1991). Sixty-seven different types
of HPV have now been described, and 28 have been isolated
from benign and malignant genital lesions (de Villiers, 1992).
These viruses have been further classified according to their
supposed malignant potential. 'High-risk' types (e.g. HPV 16,
18, 31, 33, 35, 51, 52) have been linked to cervical intra-
epithelial neoplasia (CIN) II and III and invasive cervical
cancer, whereas 'low-risk' types (e.g. HPV 6, 11, 42, 43, 44)
have been associated with condylomata acuminata and CIN I
(Howley, 1991; Lorincz et al., 1992).
Epidemiological studies investigating the relation between
HPV and cervical neoplasia have found strong associations
(Munoz & Bosch, 1992). However, some of these studies are
difficult to interpret because of methodological flaws in study
design (Munoz et al., 1988) or because of the inaccuracy of
the hybridisation techniques used to detect HPV DNA
(Schiffman, 1992). Recently a reliable and sensitive HPV
detection strategy based on the polymerase chain reaction
(PCR) has been developed in several laboratories (Manos et
al., 1989; van den Brule et al., 1990) and is now considered
the technique of choice for epidemiological studies
(Schiffman, 1992). Employing this technique, two recent
studies have found high risks of cervical cancer associated
with HPV (Peng et al., 1991; Munoz et al., 1992).
In developing countries cancer of the cervix is the leading
cancer even when sites common to both sexes are combined
(Parkin et al., 1988). This hospital-based case-control study
using PCR was undertaken to examine the role of HPV in
the development of invasive cervical cancer in Sao Paulo,
Brazil, a city with one of the highest incidence rates of this
disease worldwide (Muir et al., 1987).
Patients and methods
Studypopulation
Between June 1990 and June 1991 women with a diagnosis of
invasive cervical cancer and women selected as controls were
recruited from seven hospitals in Sao Paulo City. Five of
these are general hospitals, and two are hospitals for the
treatment of cancer. The cases were women between 25 and
79 years of age, whose diagnosis was confirmed by histo-
pathology and who had had no previous treatment for the
disease. Controls were enrolled from the same five general
hospitals from which the cases were recruited. For cases from
the hospitals in which only cancer patients are treated
(n = 48), controls were selected from the largest general hos-
pital included in the study. This was because had the cancer
cases had another disease it is likely that they would have
been treated there as it is the most commonly used referral
hospital in the city. Controls were frequency matched to
cases in 5-year age groups. Those with diseases associated
with known risk factors for cervical neoplasia were excluded
(sexually transmitted diseases, coronary heart disease, cere-
brovascular disease, arterial thromboembolism, thrombo-
phlebitis, chronic bronchitis, emphysema, neoplasia of the
breast, reproductive and respiratory organs, anus, oral cavity,
oesophagus, bladder and liver). Women who were admitted
for treatment of a gynaecological condition or who had had
a hysterectomy or conisation were ineligible as controls.
Women with a psychiatric illness were ineligible as cases or
as controls. Evidence of a gynaecological or cytological
abnormality detected on examination after recruitment was
not a criterion for exclusion.
A total of 206 women with invasive cervical cancer and
238 controls were eligible for investigation; 199 (96.6%) and
225 (94.5%), respectively, agreed to be interviewed. Reasons
for non-participation were refusal (three cases, 11 controls),
death (three cases) and inability to locate (one case, two
controls). Of the 199 cases, 178 (89.4%) had squamous cell
carcinoma, nine (4.5%) adenocarcinoma, nine (4.5%) adeno-
squamous carcinoma and three (1.5%) undifferentiated car-
cinoma. The diagnoses for the 225 controls were diseases of
the circulatory system (48), infectious and parasitic diseases
(29), diseases of the digestive system (25), endocrine diseases
(23), neoplasms (22), diseases of the nervous system and
sense organs (17), diseases of the respiratory system (16) and
various other conditions (45). In order to be able to adjust
simultaneously for number of sexual partners and age at first
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intercourse, the analysis reported here has been limited to the
199 cases and 218 controls who reported having had at least
one sexual partner.
Data and specimen collection
Study subjects were interviewed privately in the hospital by
one of five trained personnel who were blind to their case-
control status. Using a standardised questionnaire, inform-
ation obtained included sexual behaviour, reproductive
history, contraceptive practice, smoking habits and history of
any previous Papanicolaou (Pap) smears. Care was taken to
include questions that would distinguish between the taking
of smears and other gynaecological examinations. All reports
of smears taken in the 12 months prior to interview were
omitted from the analysis as it was thought that they could
be related to case diagnosis. Several measures of socio-
economic status were investigated, including literacy, years of
schooling, educational level and income per capita. The
women were also asked whether or not they had the follow-
ing 'household facilities': mains water supply, a sewage dis-
posal system, a television set and a refrigerator. All study
participants had a pelvic examination performed by a gynae-
cologist when exfoliated cells for cytological examination and
for HPV analysis were collected. Two cases (1.0%) and nine
controls (4.1%) did not have specimens taken.
All cytology and histopathology was undertaken at the
Faculdade de Medicina, Universidade de Sao Paulo. Of the
199 biopsies, 195 (98.0%) were read by a single experienced
pathologist. Pap smears were read by one cytotechnician
supervised by the same pathologist to exclude invasive cer-
vical carcinoma in the control group. One control (0.5%)
had cytological evidence of a low-grade squamous intra-
epithelial lesion; she was retained in the study.
Sample preparation and detection ofHPV DNA
Material was collected for the HPV assays using two wooden
spatulas and two brushes. For each woman, a smear was
made by sampling cells from the ectocervix with a spatula
and from the endocervix with a brush. The spatula and brush
were then introduced into a tube containing phosphate-
buffered saline (PBS). A second sample of ectocervical and
endocervical cells was collected with a second spatula and
brush and introduced into the same tube. The tubes were
vigorously vortexed and the suspension was centrifuged for
10 min at 2000 r.p.m. The pellets were resuspended in 1.0 ml
of PBS solution and centrifuged again at 3000 r.p.m. for
10min. The pellets were stored at - 70°C. During sample
preparation care was taken to avoid contamination; the
equipment used was disposable. When the study was com-
pleted, all the material was sent for HPV DNA analysis to
the Department of Pathology at the Free University Hospital
in Amsterdam.
HPV detection was performed directly on crude cell
suspensions by a combination of general primer-mediated
and type-specific PCR (GP-PCR/TS-PCR) (Walboomers et
al., 1992). Briefly, a first screening to determine the overall
presence of HPV was performed using general primers GP
5/6 in the PCR, which permits the detection of the sequenced
genital HPV types 6, 11, 16, 18, 31 and 33 but also detects
still unsequenced genital HPV types at the subpicogram level
(Snijders et al., 1990). After low-stringency Southern blot
analysis with probes of HPV-specific PCR products, the GP-
PCR-positive scrapes were subjected to TS-PCR to establish
the specific type of HPV present. Mixtures of HPV 6, 16, 33
and HPV 11, 18, 31 specific primer sets (van den Brule et al.,
1989; Walboomers et al., 1992) were used to detect the
sequenced HPV genotypes.
TS-PCR products were identified by size determination
and by Southern blot analysis using internal oligonucleotide
probes. Scrapes that were positive by GP-PCR and negative
by TS-PCR were suspected of containing still unidentified
HPV genotypes. Special precautions taken to minimise false-
positive results in the PCR have been described in detail
elsewhere (van den Brule et al., 1990). To analyse the quality
of target DNA for PCR purposes, scrapes were subjected to
PCR using P-globin gene-specific primers. When this target of
the P-globin gene was successfully amplified it indicated that
the DNA was suitable for PCR analysis.
Statistical analysis
To estimate the risk of cervical cancer associated with
selected factors, odds ratios (OR) and 95% confidence inter-
vals (95% CI) were calculated as approximations of relative
risks using unconditional logistic regression analysis (Breslow
& Day, 1980). Potential confounding variables and interac-
tions with the factors of interest were examined using this
method. Statistical significance was assessed using the likeli-
hood ratio test (Breslow & Day, 1980). Tests for trend were
made by categorising the exposure variables and entering the
scores as continuous. As measures of socioeconomic status,
income per capita and number of household facilities showed
the strongest association with risk of cervical cancer. When
the variables of interest were adjusted by either of these
measures, the results were very similar. Since more than 12%
of women did not know the family income, and as data on
household facilities were complete, the latter was chosen as
the indicator for socioeconomic status. All odds ratios were
adjusted for age in 5-year groups (25-29, 30-34, ... 75-79
years) and for socioeconomic status in four categories (hav-
ing four, three, two and one or no household facilities).
Parity was defined as number of live and still births. Sixty-
five cases (32.7%) and 49 controls (22.5%) were not living in
Sao Paulo in the 12 months before the interview. When the
data were examined by place of residence, the risk estimates
associated with the main variables of interest were of similar
magnitude. The odds ratios were not, therefore, adjusted for
place of residence.
Results
The mean age of both cases and controls was similar, being
52.1 years and 52.4 years respectively. There was, however, a
difference in the socioeconomic status of cases and controls.
Compared with those having four household facilities, the
age-adjusted odds ratios associated with having three, two
and one or no household facilities were 1.6 (95% CI
1.0-2.7), 2.3 (95% CI 1.2-4.4) and 3.1 (95% CI 1.6-6.1)
respectively [X2 (trend) = 16.3, P<0.001]. Because of this, all
odds ratios were adjusted for socioeconomic status as well as
for age.
HPV DNA was detected in 157 (84%) of the 186 cases and
in 32 (17%) of the 190 controls with cervical specimens
(exfoliated cells) in which the P-globin gene was amplified.
Cervical specimens obtained by biopsy were available from
16 of the 29 cases whose smear was negative for HPV DNA;
in eight (50%) of them HPV DNA was detected. Although
there was a decline in the percentage of controls with HPV
DNA with increasing age, the trend was not statistically
significant [X2 (trend) = 1.92, P = 0.17]. Among cases there
was no trend in the prevalence of HPV with age [X2
(trend) = 0.08, P = 0.77] (Table I).
Cases and controls who reported having had two or more
sexual partners had a higher prevalence of HPV DNA (Table
I), but this finding was not statistically significant. The pro-
portion of cases and controls positive for HPV DNA in-
creased with increasing number of regular partners [cases:
one, 80.5%; two, 88.9%; three to five, 94.4%; x2
(trend)= 3.41, P = 0.06. Controls: one, 14.6%; two, 23.1%;
three to five, 21.4%; x2 (trend) = 1.37, P = 0.24]. Conversely,
no association was found between prevalence of HPV DNA
and number ofcasual partners [Cases: none, 84,7%; one/two,
77.8%; three or more, 88.9%; x2 (trend) = 0.02, P = 0.89.
Controls: none, 17.8%; one/two, 5.3%; three or more,
25.0%: x2 (trend) = 0.13, P = 0.72]. Although not statistically
significant, the proportion of controls positive for HPV DNA
increased the younger the age at first intercourse [x2116 J. ELUF-NETO et al.
Table I HPV prevalancea among cases and controls according to age,
number of sexual partners and age at first intercourse
Cases Controls
HPVpositive HPVpositive
No. (%) No. (G)
Age (years)
25-34 10 8 (80.0) 12 2 (16.7)
35-44 41 36 (87.8) 37 8 (21.6)
45-54 57 45 (78.9) 58 12 (20.7)
55-64 46 41 (89.1) 52 6(11.5)
65-79 32 27 (84.4) 31 4 (12.9)
Total 186 157 (84.4) 190 32 (16.8)
No. ofsexual partners
1 104 85 (81.7) 128 19 (14.8)
2-3 57 50 (87.7) 51 11 (21.6)
,_4 25 22 (88.0) 11 2 (18.2)
Age atfirst intercourse
.20 62 52 (83.9) 91 13 (14.3)
15-19 98 82 (83.7) 86 15 (17.4)
< 14 26 23 (88.5) 13 4 (30.8)
aTwo cases and nine controls did not have specimens taken. In 11
cases and 19 controls the P-globin gene was not amplified.
(trend) = 1.69, P = 0.19] (Table I). In both cases and controls
no association was found between HPV prevalence and
socioeconomic status, parity, number of Pap smears, smok-
ing habits or years of oral contraceptive use.
The factor most strongly related to the risk of cervical
cancer was the presence of HPV DNA (OR = 37.1, 95% CI
19.6-70.4) (Table II). Other factors significantly related to
risk were number of sexual partners [X2 (trend) = 8.9,
P = 0.003], age at first intercourse [X2 (trend) = 8.1,
P = 0.004], parity [X2 (trend) = 21.2, P<0.001] and duration
of oral contraceptive use [X2 (trend) = 8.2, P = 0.004]. There
was a strong protective effect associated with number of Pap
smears [X2 (trend)= 55.1, P<0.001]. The risk of cervical
cancer associated with ever having smoked was of borderline
significance (OR = 1.51, P = 0.055). No trend of increasing
risk was observed with increasing number of cigarettes
smoked per day or with years of use.
Except for HPV 6 (only one control positive) and HPV 11
(no participant positive), all the other types of HPV investi-
gated were highly associated with risk. Eighty-four per cent
of the cases were positive for HPV compared with 17% of
controls. The most common type of HPV among cases was
HPV 16, whereas among controls unidentified HPV types
were the most frequent. There were six cases but no controls
infected with HPV 31 or HPV 33. Double infections were
found only in cases. Grouping high-risk types (HPV 16/18/
31/33), almost 66% of the cases were positive compared with
only 6% of the controls. The odds ratio of cervical cancer
associated with these types was 75.1 (95% CI 34.2-165.0)
(Table III).
Table IV shows the risks associated with each of the
factors found to have been significantly related to cervical
cancer risk after adjustment for age, socioeconomic status
and all the other factors in the table. Only detection of HPV
DNA, number of Pap smears and parity remained indepen-
dently associated with risk of cervical cancer. The risks
associated with the HPV types investigated remained almost
unchanged from those shown in Table III.
Table V shows the interactions of HPV detection with
smoking habits and duration of oral contraceptive use.
Although there appears to be a stronger effect of smoking in
the HPV-negative stratum, the term for interaction was not
significant (P = 0.18). The use of oral contraceptives for 5 or
more years was associated with a higher risk in the HPV-
positive stratum. However, in this stratum the use of oral
contraceptives for a shorter period was not associated with
an increased risk of cervical cancer when compared with
never-users (the odds ratio was even lower). Therefore, the
term for interaction had a large P value (0.81). Although
there was no significant interaction between HPV detection
Table II Odds ratios for invasive cervical cancer associated with
selected factors
Riskfactor Cases Controls OR (95% CI)a
Any HPV typeb
Negative 29 158 1.00
Positive 157 32 37.11 (19.56-70.44)
No. ofsexual partners
1 108 145 1.00
2 45 40 1.61 (0.96-2.69)
3 16 20 1.16 (0.56-2.40)
.4 30 13 3.32 (1.57-7.03)
X2 for trend = 8.94, P = 0.003
Age atfirst intercourse
.20 65 106 1.00
15-19 107 98 1.68 (1.10-2.57)
< 14 27 14 2.38 (1.12-5.05)
x2 for trend = 8.12, P = 0.004
Parity
0- 1 12 31 1.00
2-3 31 67 1.25 (0.55-2.81)
4-5 49 45 2.92 (1.30-6.57)
6-7 30 34 2.33 (0.98-5.55)
8-9 33 18 4.71 (1.86-11.92)
.10 44 23 4.89 (1.99-12.01)
x2 for trend=21.18, P=0.001
No. ofPap smearsc
None 134 74 1.00
1-2 44 61 0.41 (0.25-0.68)
3-5 13 32 0.22 (0.11-0.47)
.6 7 50 0.08 (0.03-0.19)
x2 for trend = 55.05, P = 0.001
Smoking habits
Never smoked 111 143 1.00
Ever smoked 88 75 1.51 (0.99-2.30)
Oral contraceptive use (years)d
Never used 125 152 1.00
1-4 39 44 1.29 (0.73-2.28)
)5 33 22 2.68 (1.39-5.19)
X2 for trend = 8.16, P = 0.004
'All odds ratios adjusted for age and socioeconomic status. bTwo
cases and nine controlsdid not have specimens taken. In 11 casesand 19
controls theP-globin gene was not amplified. cData missing foronecase
and one control. dData missing for two cases.
Table III Prevalence ofdifferent types ofHPV DNA amongcases and
controls and associated odds ratios for invasive cervical cancer'
HPV types Cases (%) Controls (%) ORb (95% CI)
Negative 29 (15.6) 158 (83.2) 1.0c
Any type 157 (84.4) 32 (16.8) 37.1 19.6-70.4
100 (53.8) 10 (5.3) 74.9 32.5-173
18e 16 (8.6) 2 (1.1) 56.9 11.7-276
31/33 6 (3.2) 0 (0.0) -
16/18/31/33 122 (65.6) 12 (6.3) 75.1 34.2-165
Not identified 35 (18.8) 19 (10.0) 13.8 6.4-29.6
6 0 (0.0) 1 (0.5) -
Double infection' 8 (4.3) 0 (0.0)
'Two cases and nine controls did not have specimens taken. In 11
cases and 19 controls the P-globin gene was not amplified. bAll odds
ratios adjusted for age and socioeconomic status. cReference group.
dIncludes twocases also positive forHPV 18, two cases also positive for
HPV33andonecasealsopositive foranunidentified type.'Includesone
casealsopositive foranunidentified type. fIncludes thesixcasesreferred
to in d and e and two cases positive for HPV 31 and 33.
and parity, a stronger effect of parity was observed among
women positive for HPV. This result will be described
elsewhere.
There was no difference in the HPV prevalence among
women with squamous cell carcinoma (84.9%) and adeno-
carcinoma/adenosquamous carcinoma (83.3%). There was,
however, a higher prevalence of HPV 18 in women with
adenocarcinoma/adenosquamous carcinoma (22.2%) than in
those with squamous cell carcinoma (8.4%). There was aHPV AND CERVICAL CANCER IN BRAZIL 117
Table IV Odds ratios for the factors found to be significant related to
cervical cancera
Riskfactor OR 95% CI
HPV type
Negative 1.00
Not identified 12.04 5.08-28.51
16/18/31/33 69.70 28.65-169.6
No. ofPap smears
None 1.00
1-2 0.40 0.18-0.89
3-5 0.20 0.06-0.62
>6 0.12 0.03-0.41
X2 for trend= 17.95, P<0.001
Parity
0-1 1.00
2-3 1.27 0.35-4.58
4-5 2.22 0.61-8.05
6-7 1.73 0.43-6.99
8-9 3.95 0.92-16.90
>10 4.08 0.95-17.42
x2 for trend= 5.38, P= 0.02
No. ofsexualpartners
I 1.00
2 0.97 0.40-2.37
3 1.13 0.31-4.07
>4 3.38 0.94-12.21
x2for trend = 2.53, P= 0.11
Age atfirst intercourse
>20 1.00
15-19 1.43 0.67-3.06
< 14 1.27 0.36-4.54
x2 for trend = 0.48, P= 0.49
Oral contraceptive use (years)
Never used 1.00
1-4 1.16 0.44-3.06
>5 2.51 0.87-7.30
x2 for trend = 2.54, P = 0.11
'All odds ratios adjusted for age, socioeconomic status and the other
factors shown in the table.
Table V Odds ratioa for invasive cervical cancer associated with HPV
detection according to smoking and duration of oral contraceptive
use
HPV DNA
Factor Negative Positive
Smoking habits
Never smoked 1.00 49.11 (19.62-122.9)
Ever smoked 2.27 (0.88-5.86) 45.00 (15.87-127.6)
Oral contraceptive use (years)
Never used 1.00 37.72 (16.04-88.67)
1-4 2.69 (0.77-9.42) 29.61 (9.05-96.84)
>5 2.06 (0.52-8.24) 218.4 (36.17-1318)
'All odds ratios adjusted for age, socioeconomic status, number of
Pap smears, parity, number of sexual partners, age at first intercourse
and years of oral contraceptive use.
lower prevalence of HPV among cases with more advanced
disease (93% in stage I, 80.6% in stage II and 82.5% in
stages III-IV).
Discussion
This is the first case-control study of invasive cervical cancer
ever reported from Brazil. We found that 84% of cervical
cancer cases had HPV DNA in their cervical smears as
detected by PCR. This is similar to the prevalence found in a
French study (84%) (Riou et al., 1990) and in an Australian
study (80%) (Higgins et al., 1991), in which cervical car-
cinoma specimens were obtained by biopsy or surgical ex-
cision. It should be stressed that a further eight cases had a
negative smear but a positive biopsy for HPV DNA. A low
number of neoplastic cells in the smears in combination with
the presence of blood, cervical flora and mucus may inhibit
amplification when exfoliated cells are used. When a biopsy
is taken a piece oftissue that is more likely to contain mainly
malignant cells is selected. Thus, the true HPV prevalence
among the cases could have been even higher. On the other
hand, despite the precautions taken, there is the possibility of
false positives in the smears. Although PCR is now con-
sidered the technique of choice for epidemiological studies,
no comparisons of the leading PCR-based strategies have so
far been carried out (Schiffman, 1992).
The prevalence of 'high-risk' types (16/18/31/33) was 66%
among our cases. Seventeen per cent of controls had HPV
DNA, but only 6% contained the DNA sequences for the
types commonly associated with cervical cancer. Although
not statistically significant, among controls there was a de-
cline in the HPV prevalence with increasing age, a finding
also demonstrated in other studies (Ley et al., 1991; Melkert
et al., 1993). In contrast, among cases, HPV prevalence was
persistently high in all age groups. This could indicate that
many women acquire HPV although most would suppress or
lose the infection. A few with continuous infection may go
on to develop cervical intraepithelial neoplasia that even-
tually might evolve to invasive disease, while others become
chronic carriers of the infection. That many genital HPV
infections are transient has been suggested by others (Ley et
al., 1991; Melkert et al., 1993).
No significant association was found between the preva-
lence of HPV infection and number of sexual partners.
Similar findings from previous studies (Reeves et al., 1989;
Villa & Franco, 1989; Kjaer et al., 1990) have been partially
attributed to the low accuracy of the HPV detection tech-
nique used, filter in situ hybridisation (FISH) (Schiffman,
1992). The consequence of non-differential misclassification
of HPV status has been addressed recently by Franco (1991),
who suggests that even low levels of misclassification might
deform the association between sexual activity and HPV
infection. However, results from a recent cross-sectional
study involving 467 women have shown a strong correlation
between HPV infection detected by PCR and number of
sexual partners (Ley et al., 1991). That in the current study
no statistically significant association was found, despite
using PCR, may be because only 33% of the women in this
control group reported having had more than one sexual
partner compared with 81% of those in their investigation.
Furthermore, the mean age in this study was 52 years com-
pared with only 23 years in the cross-sectional study (only 25
women were 30 years old or more). If HPV infection can be
transient in women with normal cervices, PCR will not iden-
tify all women who have ever been infected. This could
explain the lack of association between number of sexual
partners and HPV DNA detection among older women.
However, in this study the number of controls positive for
HPV DNA was too small to permit stratification by both age
and number of sexual partners. Nevertheless, two recent
cross-sectional studies employing PCR have not found any
association between HPV detection and number of sexual
partners (Rohan et al., 1991; Kjaer et al., 1993). Another
explanation could be the partners' sexual behaviour. The
'male factor' will be addressed in a future report.
Increasing number of regular partners tended to be
associated with higher HPV prevalence, mainly among cases,
whereas no association at all was found with increasing
number of casual partners. It could be conceived that to
acquire and have persistent infection frequent contacts with
an infected partner would be usually needed. However, as the
natural history of HPV infection is only just beginning to be
understood, this is merely speculation. Another possibility
could be that there is more chance of misclassification for
number of casual partners than for number of regular part-
ners.
We found presence of HPV DNA, early age at first inter-
course, increasing number of sexual partners, increasing
parity and increasing duration of oral contraceptive use to be118 J. ELUF-NETO et al.
significantly related to an increased risk and number of Pap
smears to be significantly related to a decreased risk of
cervical cancer. However, in a multivariate analysis in which
all the variables were adjusted for each other as well as for
age and socioeconomic status, only HPV DNA, number of
Pap smears and parity remained as independent risk factors.
While the efficacy of cytological screening has never been
evaluated by a randomised trial, many studies have found
evidence of protection against the development of cervical
cancer (Day, 1989). It should be emphasised that in this
study misclassification of Pap smear history should have been
minimised as questions were included to help women distin-
guish between the taking of smears and other gynaecological
procedures. In some previous studies the association found
between increased parity and cancer of the cervix was as-
cribed to the association with sexual behaviour. However,
two recent investigations have demonstrated an independent
effect (Brinton et al., 1989; Parazzini et al., 1989). The risk of
cervical cancer associated with presence of the 'high-risk'
HPV types 16/18/31/33 was 69.7 (95% CI 28.7-169.6). Risks
of such magnitude are rarely found in epidemiological
studies, being even higher than those found with hepatitis B
virus for hepatocellular carcinoma (Trichopoulos et al.,
1987). A large case-control study conducted in various Latin
American countries has found a relative risk of 2.1 (95% CI
1.6-2.8) associated with low signal intensity and 9.1 (95% CI
6.1- 13.6) with high signal intensity for HPV 16/18 using
filter in situ hybridisation (Reeves et al., 1989). However, this
assay is now considered as the least accurate hybridisation
test for the detection of HPV DNA (Schiffman, 1992). Three
studies, in which the PCR technique was used, also found
high risks for cervical neoplasia associated with HPV (Mor-
rison et al., 1991; Peng et al., 1991; Munoz et al., 1992). In
China, the risk of invasive cervical cancer associated with
HPV types 16/33 was 32.9 (95% CI 7.7-141.1) (Peng et al.,
1991). In a population-based case-control study of invasive
cervical cancer the risk related to any type of HPV DNA was
15.6 (95% CI 6.9-34.7) in Colombia and 46.2 (95%
CI 18.5-115.1) in Spain (Munoz et al., 1992). Results from a
case-control study conducted in the USA have shown a risk
of 7.2 (95% CI 2.4-21.9) for cervical squamous intra-
epithelial lesions associated with one HPV type and 43.0
(95% CI 6.9-266.6) associated with more than one type
(Morrison et al., 1991).
It has been postulated that smoking (Herrero et al., 1989)
and oral contraceptive use (Bosch et al., 1992) might interact
with HPV in the aetiology of cervical cancer. In this study
there was no evidence ofinteraction between HPV and smok-
ing. Nor was there a statistically significant interaction
between HPV and duration of oral contraceptive use, a
finding that was demonstrated in the study from Colombia
and Spain (Bosch et al., 1992). An increased risk associated
with HPV infection was found among women who used oral
contraceptives for longer periods. Although this finding could
be due to chance, it is in agreement with oral contraceptives
acting as a promoter for other risk factor(s), in this circum-
stance HPV. Nevertheless, some investigators suggest that the
role of exogenous mutagenic factors may have been overem-
phasised previously (zur Hausen, 1991).
It should be pointed out that the small number of HPV-
positive controls (32) and of HPV-negative cases (29) limits
the possibility of detecting statistically significant interactions
between HPV and the other risk factors for cervical cancer.
This lack of power has also been a limitation of other
studies. Specially designed case-control studies matched on
HPV status might increase the power.
With a case-control design one cannot be sure whether the
HPV infection preceded or post-dated the disease. In addi-
tion, it might be easier to detect HPV in infected cancer cells
rather than in infected non-malignant cells. So far, only a few
small follow-up studies have been published with results that
have no clear interpretation (Munoz & Bosch, 1992). How-
ever, a recent follow-up study of 241 women with normal
cytology has found a relative risk of 11 (95% CI 4.6-26) for
the development of CINII-III related to infection with HPV
16/18 (Koutsky et al., 1992).
Our study had limitations in that it was hospital based and
not restricted to women with permanent residence in Sao
Paulo. However, we selected controls with a wide range of
diagnoses, the risks estimates associated with the main
variables of interest were similar when examined by place of
residence, 98% of our cases had their biopsies read by a
single experienced pathologist, cases were restricted to
invasive stages and extreme care was employed during
sample preparation and in the PCR analysis to avoid con-
tamination. Furthermore, risks of this magnitude can hardly
be explained by the limitations outlined above. The experi-
mental evidence for the malignant potential of HPV and the
very high risks found in this study, particularly in relation to
HPV types 16, 18, 31 and 33, further implicates this virus in
the aetiology of cervical cancer.
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